Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

A Brilacidin deal is the linchpin to our prosperity. I agree that without it, existing shareholders will lose a substantial amount of equity in the company. This includes the company officers.

If they were holding out because they were only getting 50% of what they wanted, they will lose that in dilution anyway by holding out.

We utilized self-financing as best we could to maximize the pipeline value and now it's time to get final appraisals and sign the best deal.

What is your opinion on the feasibility of something like the following:

1) $50 million upfront + $200 million milestones + 15% royalties on B licensing

2) $200-600 million buyout of B and K

A BP would be locking up a huge amount of pipeline potential for just a few hundred million. We see many examples of me-too pre-clinical IO targets getting $100 million upfront payments.

Either of those deals rocket the stock price back to $1 or more. I would suspect numerous BPs would be interested in one or the other given their large cash reserves and flagging pipelines. It doesn't take a very large deal to improve our position substantially.